Purpose An update of the recommendations for the prophylaxis of acute and delayed
emesis induced by moderately emetogenic chemotherapy published after the last …

Purpose The purpose of this review is to update the MASCC (Multinational Association of
Supportive Care in Cancer) guidelines for controlling nausea and vomiting with …

Background Evidence-based antiemetic guidelines offer predominantly consistent
recommendations for chemotherapy-induced nausea and vomiting (CINV) prophylaxis …

Learning Objectives After completing this course, the reader will be able to: Explain the
optimal antiemetic prophylaxis for patients receiving chemotherapy in regard to the …

Chemotherapy-induced nausea and vomiting is one of the most worrisome adverse effects
of chemotherapy for cancer patients. It can cause severe discomfort and affect the quality of …

Purpose An update of the recommendations for the prophylaxis of delayed emesis induced
by moderately emetogenic chemotherapy discussed during the third Perugia Consensus …

This paper is a review of the recommendations for the prophylaxis of acute emesis induced
by moderately emetogenic chemotherapy as concluded at the third Perugia Consensus …

Background Guideline-recommended antiemetic prophylaxis improves nausea and vomiting
control in most patients undergoing chemotherapy. Multinational Association of Supportive …

Purpose This review summarizes the recommendations for the prophylaxis of nausea and
vomiting in adults receiving highly emetogenic chemotherapy (HEC) which includes …

Background: Clinician adherence to antiemetic guidelines for preventing chemotherapy-
induced nausea and vomiting (CINV) caused by highly emetogenic chemotherapy (HEC) …